BR
B.O.S.S. Retirement Advisors, LLC
13F filer · CIK 0001964810Reported Jul 20, 2026
Net buyer this quarter
13F portfolio value$370MU.S. long equity reported on 13F
Positions8411 new · 18 closed
Net flow last quarter+$7.35MBuys minus sells
Top 10 positions weight14.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 20, 202684 positions | |||||
| $13.1M | 3.52% | 0.00% | +6.5% | Q4 2022 | |
| $6.97M | 1.88% | 0.00% | +0.9% | Q4 2022 | |
| $6.4M | 1.73% | Not reported | Not reported | Q2 2024 | |
| OBONEZOne Bio, Corp. | $5.41M | 1.46% | Not reported | +164.6% | Q2 2025 |
| $5.39M | 1.46% | 0.00% | -3.5% | Q4 2022 | |
| $5.2M | 1.40% | 0.00% | +19.5% | Q4 2022 | |
| $4.08M | 1.10% | 0.00% | +5.3% | Q4 2022 | |
| $3.39M | 0.92% | 0.00% | -10.0% | Q4 2022 | |
| $2.73M | 0.74% | Not reported | +6.1% | Q4 2024 | |
| $2.59M | 0.70% | 0.00% | +2.6% | Q4 2022 | |
| $2.17M | 0.59% | 0.03% | +30.3% | Q3 2025 | |
| $2.15M | 0.58% | 0.63% | -31.0% | Q2 2025 | |
| $1.91M | 0.52% | Not reported | +19.3% | Q4 2022 | |
| $1.67M | 0.45% | 0.00% | -0.1% | Q4 2025 | |
| $1.63M | 0.44% | 0.00% | -16.4% | Q3 2024 | |
| $1.54M | 0.41% | Not reported | +10.7% | Q4 2022 | |
| $1.45M | 0.39% | Not reported | -3.9% | Q1 2026 | |
| $1.37M | 0.37% | 0.00% | -2.4% | Q4 2022 | |
| $1.2M | 0.32% | 0.00% | +5.2% | Q4 2022 | |
| $1.12M | 0.30% | 0.00% | -4.4% | Q4 2022 | |
| $1.11M | 0.30% | 0.02% | Not reported | Q2 2025 | |
| $946K | 0.26% | 0.00% | +0.9% | Q4 2022 | |
| $895K | 0.24% | Not reported | -14.9% | Q4 2022 | |
| $778K | 0.21% | 0.00% | +13.1% | Q4 2022 | |
| $748K | 0.20% | Not reported | +4.0% | Q4 2022 | |
| $738K | 0.20% | Not reported | Not reported | Q4 2025 | |
| $687K | 0.19% | Not reported | -15.8% | Q2 2023 | |
| $677K | 0.18% | 1256.93% | -0.9% | Q4 2022 | |
| $677K | 0.18% | 0.00% | -19.2% | Q3 2025 | |
| $651K | 0.18% | 0.00% | +0.7% | Q4 2022 | |
| $642K | 0.17% | 0.00% | +6.0% | Q4 2022 | |
| $634K | 0.17% | Not reported | New | Q2 2026 | |
| $630K | 0.17% | 0.00% | -1.6% | Q4 2022 | |
| $625K | 0.17% | 0.06% | Not reported | Q3 2025 | |
| $573K | 0.15% | 0.00% | +3.0% | Q4 2022 | |
| $540K | 0.15% | 0.00% | +7.7% | Q4 2022 | |
| $512K | 0.14% | 0.00% | -8.9% | Q4 2022 | |
| $503K | 0.14% | 0.00% | Not reported | Q4 2022 | |
| $502K | 0.14% | Not reported | +11.7% | Q4 2022 | |
| $500K | 0.13% | 0.00% | -3.8% | Q1 2026 | |
| $495K | 0.13% | 0.00% | -26.8% | Q3 2024 | |
| $490K | 0.13% | 0.00% | Not reported | Q1 2025 | |
| $455K | 0.12% | 0.00% | +22.2% | Q4 2024 | |
| $445K | 0.12% | 0.00% | -1.0% | Q2 2023 | |
| $443K | 0.12% | 0.01% | -0.3% | Q4 2022 | |
| $442K | 0.12% | Not reported | +4.1% | Q4 2022 | |
| $428K | 0.12% | 0.00% | +5.0% | Q4 2022 | |
| $415K | 0.11% | 0.00% | +9.5% | Q1 2023 | |
| $408K | 0.11% | 0.00% | +0.6% | Q2 2025 | |
| $403K | 0.11% | 0.00% | -25.7% | Q3 2024 | |
| Q1 2026Reported Apr 28, 202691 positions | |||||
| $13.1M | 3.98% | 0.00% | +127.0% | Q4 2022 | |
| $6.02M | 1.84% | 0.00% | -10.5% | Q4 2022 | |
| $4.9M | 1.49% | 0.00% | +16.4% | Q4 2022 | |
| $4.32M | 1.32% | 0.00% | -5.4% | Q4 2022 | |
| $3.39M | 1.03% | 0.00% | -5.4% | Q4 2022 | |
| $3.33M | 1.01% | 0.00% | -2.1% | Q4 2022 | |
| $2.61M | 0.80% | 0.91% | +4.1% | Q2 2025 | |
| $2.03M | 0.62% | 0.00% | -3.5% | Q4 2022 | |
| $1.98M | 0.60% | 0.03% | +26.6% | Q3 2025 | |
| OBONEZOne Bio, Corp. | $1.86M | 0.57% | Not reported | -5.0% | Q2 2025 |
| $1.62M | 0.50% | Not reported | -4.4% | Q4 2022 | |
| $1.5M | 0.46% | Not reported | -8.0% | Q4 2024 | |
| $1.33M | 0.40% | 0.00% | -2.5% | Q4 2022 | |
| $1.32M | 0.40% | Not reported | New | Q1 2026 | |
| $1.26M | 0.38% | 0.00% | +50.6% | Q4 2025 | |
| $1.17M | 0.36% | 0.02% | Not reported | Q2 2025 | |
| $1.15M | 0.35% | 0.00% | +24.3% | Q4 2022 | |
| $1.13M | 0.34% | Not reported | -13.2% | Q4 2022 | |
| MMASIMasimo Corp | $949K | 0.29% | 0.01% | Not reported | Q4 2024 |
| $931K | 0.28% | Not reported | -13.6% | Q4 2022 | |
| $808K | 0.25% | 0.00% | Not reported | Q4 2022 | |
| $803K | 0.24% | 1268.44% | Not reported | Q4 2022 | |
| $779K | 0.24% | 0.00% | -3.3% | Q4 2022 | |
| $710K | 0.22% | Not reported | -4.1% | Q2 2023 | |
| $632K | 0.19% | 0.00% | +1.4% | Q4 2022 | |
| $623K | 0.19% | 0.00% | -4.1% | Q4 2022 | |
| $623K | 0.19% | 0.00% | -11.8% | Q4 2022 | |
| $597K | 0.18% | 0.00% | -0.8% | Q3 2023 | |
| $581K | 0.18% | 0.00% | -21.6% | Q4 2022 | |
| $572K | 0.17% | 0.00% | +23.5% | Q3 2024 | |
| $564K | 0.17% | Not reported | -1.3% | Q4 2022 | |
| $518K | 0.16% | 0.06% | Not reported | Q3 2025 | |
| $510K | 0.16% | Not reported | Not reported | Q4 2025 | |
| $508K | 0.15% | 0.00% | Not reported | Q4 2022 | |
| $505K | 0.15% | 0.00% | -3.7% | Q4 2022 | |
| $476K | 0.14% | 0.00% | -77.1% | Q4 2022 | |
| $468K | 0.14% | 0.00% | -7.8% | Q4 2022 | |
| $454K | 0.14% | 0.00% | -32.7% | Q4 2022 | |
| $450K | 0.14% | 0.00% | New | Q1 2026 | |
| $449K | 0.14% | 0.00% | -19.1% | Q3 2024 | |
| $446K | 0.14% | 0.00% | -0.6% | Q3 2025 | |
| $431K | 0.13% | Not reported | -0.2% | Q4 2022 | |
| $429K | 0.13% | 0.00% | -1.4% | Q4 2022 | |
| $426K | 0.13% | 0.01% | -1.1% | Q4 2022 | |
| $409K | 0.12% | 0.00% | +0.8% | Q2 2025 | |
| $409K | 0.12% | 0.00% | -1.0% | Q4 2024 | |
| $408K | 0.12% | 0.00% | -13.5% | Q2 2023 | |
| $400K | 0.12% | 0.00% | -5.2% | Q4 2022 | |
| $399K | 0.12% | Not reported | -11.7% | Q4 2022 | |
| $365K | 0.11% | 0.00% | Not reported | Q1 2025 | |
| Q4 2025Reported Feb 2, 202692 positions | |||||
| $7.2M | 2.27% | 0.00% | -7.2% | Q4 2022 | |
| $5.96M | 1.88% | 0.00% | -18.6% | Q4 2022 | |
| $4.98M | 1.57% | 0.00% | +5.5% | Q4 2022 | |
| $4.5M | 1.42% | 0.00% | -15.6% | Q4 2022 | |
| $4.11M | 1.29% | 0.00% | -12.5% | Q4 2022 | |
| $3.97M | 1.25% | 0.00% | -24.0% | Q4 2022 | |
| $2.67M | 0.84% | 0.88% | +142.7% | Q2 2025 | |
| $2.29M | 0.72% | 0.00% | -20.1% | Q4 2022 | |
| OBONEZOne Bio, Corp. | $2.03M | 0.64% | Not reported | -41.0% | Q2 2025 |
| $1.96M | 0.62% | Not reported | -12.9% | Q4 2022 | |
| $1.91M | 0.60% | 0.01% | +266.1% | Q4 2022 | |
| $1.53M | 0.48% | Not reported | -11.3% | Q4 2024 | |
| $1.43M | 0.45% | 0.02% | +169.3% | Q3 2025 | |
| $1.42M | 0.45% | Not reported | -44.9% | Q4 2022 | |
| $1.25M | 0.39% | 0.00% | -22.8% | Q4 2022 | |
| $1.11M | 0.35% | 0.02% | Not reported | Q2 2025 | |
| $1.04M | 0.33% | Not reported | -65.0% | Q4 2022 | |
| $1.03M | 0.32% | 0.00% | -10.2% | Q4 2022 | |
| $982K | 0.31% | 1268.44% | -0.3% | Q4 2022 | |
| $910K | 0.29% | 0.00% | -57.2% | Q4 2022 | |
| $827K | 0.26% | 0.00% | +5.6% | Q4 2022 | |
| $812K | 0.26% | 0.00% | -61.5% | Q4 2022 | |
| $795K | 0.25% | 0.00% | New | Q4 2025 | |
| $778K | 0.24% | Not reported | -67.3% | Q4 2022 | |
| $776K | 0.24% | Not reported | -4.5% | Q2 2023 | |
| MMASIMasimo Corp | $694K | 0.22% | 0.01% | Not reported | Q4 2024 |
| $680K | 0.21% | 0.00% | -15.5% | Q4 2022 | |
| $652K | 0.21% | 0.00% | +3.3% | Q4 2022 | |
| $648K | 0.20% | 0.00% | -56.9% | Q4 2022 | |
| $633K | 0.20% | 0.00% | Not reported | Q3 2023 | |
| $608K | 0.19% | Not reported | -72.3% | Q4 2022 | |
| $597K | 0.19% | 0.00% | -11.0% | Q2 2023 | |
| $574K | 0.18% | 0.00% | -1.6% | Q4 2022 | |
| $543K | 0.17% | 0.00% | -59.0% | Q4 2022 | |
| $531K | 0.17% | 0.00% | +68.9% | Q4 2022 | |
| $469K | 0.15% | 0.00% | Not reported | Q1 2025 | |
| $462K | 0.15% | Not reported | -70.1% | Q4 2022 | |
| $461K | 0.15% | 0.00% | +2.8% | Q4 2022 | |
| $454K | 0.14% | 0.00% | -25.4% | Q4 2022 | |
| $453K | 0.14% | Not reported | -15.2% | Q4 2022 | |
| $449K | 0.14% | 0.00% | -58.6% | Q3 2024 | |
| $445K | 0.14% | Not reported | -60.0% | Q4 2022 | |
| $429K | 0.14% | Not reported | New | Q4 2025 | |
| $419K | 0.13% | 0.00% | -4.5% | Q4 2022 | |
| $411K | 0.13% | 0.01% | -24.0% | Q1 2025 | |
| $391K | 0.12% | 0.00% | -2.1% | Q3 2024 | |
| $387K | 0.12% | 0.00% | -59.0% | Q4 2022 | |
| $379K | 0.12% | 0.00% | -3.5% | Q2 2024 | |
| $370K | 0.12% | 0.00% | +1.9% | Q4 2024 | |
| $367K | 0.12% | 0.00% | +1.8% | Q2 2025 | |
| Q3 2025Reported Nov 5, 202598 positions | |||||
| $7.85M | 1.88% | 0.00% | -0.5% | Q4 2022 | |
| $7.76M | 1.86% | 0.00% | -5.6% | Q4 2022 | |
| $5.07M | 1.21% | 0.00% | -56.4% | Q4 2022 | |
| $5M | 1.19% | 0.00% | +17.3% | Q4 2022 | |
| $4.97M | 1.19% | 0.00% | +4.5% | Q4 2022 | |
| $4.65M | 1.11% | 0.00% | +1.4% | Q4 2022 | |
| OBONEZOne Bio, Corp. | $3.51M | 0.84% | Not reported | +77.1% | Q2 2025 |
| $2.95M | 0.71% | Not reported | -12.1% | Q4 2022 | |
| $2.5M | 0.60% | Not reported | +8.0% | Q4 2022 | |
| $2.33M | 0.56% | Not reported | -14.0% | Q4 2022 | |
| $2.23M | 0.53% | 0.00% | -6.9% | Q4 2022 | |
| $2.15M | 0.51% | Not reported | +15.9% | Q4 2022 | |
| $2M | 0.48% | Not reported | +5.4% | Q4 2022 | |
| $1.99M | 0.48% | 0.00% | -12.2% | Q4 2022 | |
| $1.98M | 0.47% | 0.00% | -5.3% | Q4 2022 | |
| $1.66M | 0.40% | 0.00% | -5.7% | Q4 2022 | |
| $1.58M | 0.38% | Not reported | -11.5% | Q4 2022 | |
| $1.57M | 0.37% | Not reported | -2.6% | Q4 2024 | |
| $1.46M | 0.35% | 0.00% | -5.0% | Q4 2022 | |
| $1.39M | 0.33% | 0.00% | -6.3% | Q4 2022 | |
| $1.37M | 0.33% | 0.02% | -2.2% | Q1 2025 | |
| $1.26M | 0.30% | 0.00% | -7.1% | Q4 2022 | |
| $1.13M | 0.27% | 0.03% | -12.6% | Q4 2022 | |
| $1.1M | 0.26% | 0.00% | +26.8% | Q4 2022 | |
| $1.08M | 0.26% | Not reported | -21.7% | Q4 2022 | |
| $1.08M | 0.26% | 0.36% | +118.2% | Q2 2025 | |
| $994K | 0.24% | 0.00% | -7.9% | Q4 2022 | |
| $983K | 0.24% | 0.00% | -5.1% | Q3 2024 | |
| $969K | 0.23% | 1272.22% | -0.2% | Q4 2022 | |
| $949K | 0.23% | 0.00% | New | Q3 2025 | |
| $891K | 0.21% | 0.02% | Not reported | Q2 2025 | |
| $880K | 0.21% | 0.00% | -2.6% | Q4 2023 | |
| $833K | 0.20% | 0.00% | -5.8% | Q4 2022 | |
| $805K | 0.19% | 0.00% | +21.4% | Q4 2023 | |
| $799K | 0.19% | 0.00% | +1.6% | Q4 2022 | |
| $794K | 0.19% | Not reported | -31.1% | Q2 2023 | |
| MMASIMasimo Corp | $787K | 0.19% | 0.01% | +0.1% | Q4 2024 |
| $766K | 0.18% | 0.00% | -2.1% | Q2 2023 | |
| $750K | 0.18% | 0.00% | -5.8% | Q4 2022 | |
| $734K | 0.18% | 0.00% | -6.9% | Q4 2022 | |
| $704K | 0.17% | 0.00% | +17.1% | Q4 2022 | |
| $665K | 0.16% | 0.00% | -6.1% | Q4 2024 | |
| $654K | 0.16% | Not reported | -5.9% | Q4 2022 | |
| $636K | 0.15% | 0.00% | -3.5% | Q4 2022 | |
| $608K | 0.15% | 0.00% | +91.1% | Q4 2022 | |
| $575K | 0.14% | 0.01% | New | Q3 2025 | |
| $571K | 0.14% | 0.00% | +5.4% | Q4 2022 | |
| $567K | 0.14% | 0.00% | -8.6% | Q2 2024 | |
| $546K | 0.13% | 0.00% | -6.5% | Q1 2023 | |
| $534K | 0.13% | Not reported | +8.8% | Q4 2022 | |
Premium opens every quarter this fund has filed